Sageworth Trust’s Charles River Laboratories CRL Stock Holding History

Sageworth Trust’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32	Closed	-$6.46K	–	166
2023 Q1	$6.46K	Buy	32 +25	+357%	+$5.67K	﹤0.01%	343
2022 Q4	$2K	Buy	+7	New	+$1.53K	﹤0.01%	337
2021 Q2	–	Sell	-139	Closed	-$40K	–	897
2021 Q1	$40K	Hold	139	–	–	﹤0.01%	191
2020 Q4	$35K	Hold	139	–	–	﹤0.01%	135
2020 Q3	$31K	Hold	139	–	–	﹤0.01%	97
2020 Q2	$24K	Hold	139	–	–	﹤0.01%	105
2020 Q1	$18K	Hold	139	–	–	﹤0.01%	107
2019 Q4	$21K	Hold	139	–	–	﹤0.01%	126
2019 Q3	$18K	Hold	139	–	–	﹤0.01%	134
2019 Q2	$20K	Sell	139 -119	-46%	-$16.1K	﹤0.01%	128
2019 Q1	$37K	Buy	+258	New	+$33.9K	﹤0.01%	97

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Sageworth Trust's CRL Position: Q2 2023 in Review

Sageworth Trust sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 32 shares — an estimated $6.46K sold.

Sageworth Trust first reported a position in CRL in Q1 2019 and held it in 11 quarters. The position peaked at $40K in Q1 2021. 611 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

Sageworth Trust reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
Sageworth Trust sold 32 Charles River Laboratories shares in Q2 2023, an estimated $6.46K.
Sageworth Trust first reported a position in Charles River Laboratories in Q1 2019 and held it in 11 quarters.
Sageworth Trust's Charles River Laboratories position peaked at $40K in Q1 2021.
611 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.